Moderna COVID-19 Vaccine: Interim Data Show 94.5% Efficacy Moderna COVID-19 Vaccine: Interim Data Show 94.5% Efficacy

In a highly anticipated announcement, Moderna releases interim efficacy and safety data from the phase 3 COVE study of its COVID-19 vaccine.Medscape Medical News
Source: Medscape Nurses Headlines - Category: Nursing Tags: Infectious Diseases News Alert Source Type: news